Cambodia vs Middle East, North Africa, Afghanistan & Pakistan: Antiretroviral therapy coverage for PMTCT
Cambodia
97.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan
24.6%
in 2019
Cambodia rank
12th
Middle East, North Africa, Afghanistan & Pakistan rank
13th
Antiretroviral therapy coverage for PMTCT over time
- Cambodia
- Middle East, North Africa, Afghanistan & Pakistan
How they compare
Cambodia currently reports 97.0% against 24.6% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 72.4%.
That makes Cambodia's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan's.
The two have swapped places 1 time across 19 shared years of data; in 2000 it was Middle East, North Africa, Afghanistan & Pakistan ahead.
Cambodia ranks 12th and Middle East, North Africa, Afghanistan & Pakistan ranks 13th of 84 countries.
Cambodia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Middle East, North Africa, Afghanistan & Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.6% | 3.1% | 10.5% | Cambodia |
| 2010s | 63.8% | 16.8% | 47.0% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Cambodia or Middle East, North Africa, Afghanistan & Pakistan?
- Cambodia, at 97.0% against 24.6% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Cambodia and Middle East, North Africa, Afghanistan & Pakistan?
- 72.4%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Middle East, North Africa, Afghanistan & Pakistan?
- 19 years are reported by both, from 2000 to 2019.
- How do Cambodia and Middle East, North Africa, Afghanistan & Pakistan rank globally for antiretroviral therapy coverage for pmtct?
- Cambodia ranks 12th and Middle East, North Africa, Afghanistan & Pakistan ranks 13th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).